Article(id=1330184410978169228, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1330184264366272602, articleNumber=null, orderNo=null, doi=10.16522/j.cnki.cjph.2023.06.016, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1673280000000, receivedDateStr=2023-01-10, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1795070277207, onlineDateStr=2026-11-19, pubDate=1686326400000, pubDateStr=2023-06-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1795070277207, onlineIssueDateStr=2026-11-19, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1795070277207, creator=13701087609, updateTime=1795070277207, updator=13701087609, issue=Issue{id=1330184264366272602, tenantId=1146029695717560320, journalId=1319690259887390882, year='2023', volume='54', issue='6', pageStart='813', pageEnd='981', issueExtLink='null', onlineDate='null', pubDate='1686326400000', pubDateStr='2023-06-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1795070242253, creator='13701087609', updateTime=1795080494688, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1330227266719691144, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1330184264366272602, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1330227266719691145, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1330184264366272602, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=945, endPage=949, ext={EN=ArticleExt(id=1330184411229827469, articleId=1330184410978169228, tenantId=1146029695717560320, journalId=1319690259887390882, language=EN, title=Introduction and Enlightenment on Communication Mechanism of FDA Review and Approval of Complex Generic Drugs, columnId=1322624444787438528, journalTitle=Chinese Journal of Pharmaceuticals, columnName=Pharmaceutical Management & Information, runingTitle=null, highlight=null, articleAbstract=null, authors=Yangfan SHI, Xiaoling GONG, Jianzhou YAN, Rong SHAO*, authorsList=Yangfan SHI, Xiaoling GONG, Jianzhou YAN, Rong SHAO, authorCompany=null, correspAuthors=Rong SHAO, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1330184411628286350, articleId=1330184410978169228, tenantId=1146029695717560320, journalId=1319690259887390882, language=CN, title=FDA复杂仿制药审评审批沟通机制的简介与启示, columnId=1322624444934239170, journalTitle=中国医药工业杂志, columnName=药学管理与信息, runingTitle=null, highlight=null, articleAbstract=

该文通过查阅官方文件和研究文献,梳理、分析了FDA复杂仿制药注册审评过程中的沟通机制,从会议目标、细分类型、申请审核时限和会议程序几方面进行阐述,结合我国复杂仿制药审评审批沟通机制的现状,对两国复杂仿制药审评审批沟通机制进行对比和思考。FDA复杂仿制药沟通机制分为仿制药上市申请提交前程序、书面咨询和同步科学建议程序,通过细分的会议类型充分解决了复杂仿制药研发过程中审评审批层面的难题。建议我国可参考FDA做法,探索多样化的复杂仿制药沟通机制,从而提高审评效率,加快具有临床价值的复杂仿制药上市。

, authors=史扬帆, 龚小玲, 颜建周, 邵蓉*, authorsList=史扬帆, 龚小玲, 颜建周, 邵蓉, authorCompany=null, correspAuthors=邵蓉, authorNote=

史扬帆(1997—),男,硕士研究生,专业方向:医药政策与法规。

, correspAuthorsNote=
邵蓉(1962—),女,教授,博士生导师,从事医药政策与法规的研究。E-mail:
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=5fsH6ySwUxcX0x16zZnCkg==, magXml=CtNqiRdZH5TFSLnXBnEGOA==, pdfUrl=null, pdf=Bn26fnGPqj2cCAWHXzJEsQ==, pdfFileSize=1628590, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=tNx7eM5hdlQJRuUXQULH6A==, mapNumber=null, fund=null)}, authors=[Author(id=1330184412026745235, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184410978169228, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330184412127408533, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184410978169228, authorId=1330184412026745235, language=EN, stringName=Yangfan SHI, firstName=Yangfan, middleName=null, lastName=SHI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Key Lab. of Drug Regulatory Innovation and Evaluation, NMPA, Research Institute of Drug Regulatory Sciences, China Pharmaceutical University, Nanjing 211198, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330184412202906006, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184410978169228, authorId=1330184412026745235, language=CN, stringName=史扬帆, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=中国药科大学药品监管科学研究院,国家药品监督管理局药品监管创新与评价重点实验室,江苏 南京 211198, bio={"content":"

史扬帆(1997—),男,硕士研究生,专业方向:医药政策与法规。

"}, bioImg=null, bioContent=

史扬帆(1997—),男,硕士研究生,专业方向:医药政策与法规。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330184411934470543, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184410978169228, xref=null, ext=[AuthorCompanyExt(id=1330184411947053456, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184410978169228, companyId=1330184411934470543, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Key Lab. of Drug Regulatory Innovation and Evaluation, NMPA, Research Institute of Drug Regulatory Sciences, China Pharmaceutical University, Nanjing 211198), AuthorCompanyExt(id=1330184411955442065, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184410978169228, companyId=1330184411934470543, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=中国药科大学药品监管科学研究院,国家药品监督管理局药品监管创新与评价重点实验室,江苏 南京 211198)])]), Author(id=1330184412265820568, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184410978169228, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330184412383261082, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184410978169228, authorId=1330184412265820568, language=EN, stringName=Xiaoling GONG, firstName=Xiaoling, middleName=null, lastName=GONG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Key Lab. of Drug Regulatory Innovation and Evaluation, NMPA, Research Institute of Drug Regulatory Sciences, China Pharmaceutical University, Nanjing 211198, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330184412467147163, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184410978169228, authorId=1330184412265820568, language=CN, stringName=龚小玲, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=中国药科大学药品监管科学研究院,国家药品监督管理局药品监管创新与评价重点实验室,江苏 南京 211198, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330184411934470543, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184410978169228, xref=null, ext=[AuthorCompanyExt(id=1330184411947053456, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184410978169228, companyId=1330184411934470543, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Key Lab. of Drug Regulatory Innovation and Evaluation, NMPA, Research Institute of Drug Regulatory Sciences, China Pharmaceutical University, Nanjing 211198), AuthorCompanyExt(id=1330184411955442065, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184410978169228, companyId=1330184411934470543, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=中国药科大学药品监管科学研究院,国家药品监督管理局药品监管创新与评价重点实验室,江苏 南京 211198)])]), Author(id=1330184412559421853, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184410978169228, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330184412626530719, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184410978169228, authorId=1330184412559421853, language=EN, stringName=Jianzhou YAN, firstName=Jianzhou, middleName=null, lastName=YAN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Key Lab. of Drug Regulatory Innovation and Evaluation, NMPA, Research Institute of Drug Regulatory Sciences, China Pharmaceutical University, Nanjing 211198, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330184412739776928, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184410978169228, authorId=1330184412559421853, language=CN, stringName=颜建周, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=中国药科大学药品监管科学研究院,国家药品监督管理局药品监管创新与评价重点实验室,江苏 南京 211198, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330184411934470543, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184410978169228, xref=null, ext=[AuthorCompanyExt(id=1330184411947053456, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184410978169228, companyId=1330184411934470543, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Key Lab. of Drug Regulatory Innovation and Evaluation, NMPA, Research Institute of Drug Regulatory Sciences, China Pharmaceutical University, Nanjing 211198), AuthorCompanyExt(id=1330184411955442065, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184410978169228, companyId=1330184411934470543, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=中国药科大学药品监管科学研究院,国家药品监督管理局药品监管创新与评价重点实验室,江苏 南京 211198)])]), Author(id=1330184412806885794, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184410978169228, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=shaorong118@163.com, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1330184412882383268, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184410978169228, authorId=1330184412806885794, language=EN, stringName=Rong SHAO, firstName=Rong, middleName=null, lastName=SHAO, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=Key Lab. of Drug Regulatory Innovation and Evaluation, NMPA, Research Institute of Drug Regulatory Sciences, China Pharmaceutical University, Nanjing 211198, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330184412957880741, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184410978169228, authorId=1330184412806885794, language=CN, stringName=邵蓉, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=中国药科大学药品监管科学研究院,国家药品监督管理局药品监管创新与评价重点实验室,江苏 南京 211198, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330184411934470543, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184410978169228, xref=null, ext=[AuthorCompanyExt(id=1330184411947053456, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184410978169228, companyId=1330184411934470543, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Key Lab. of Drug Regulatory Innovation and Evaluation, NMPA, Research Institute of Drug Regulatory Sciences, China Pharmaceutical University, Nanjing 211198), AuthorCompanyExt(id=1330184411955442065, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184410978169228, companyId=1330184411934470543, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=中国药科大学药品监管科学研究院,国家药品监督管理局药品监管创新与评价重点实验室,江苏 南京 211198)])])], keywords=[Keyword(id=1330184413054349734, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184410978169228, language=CN, orderNo=1, keyword=复杂仿制药), Keyword(id=1330184414685933991, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184410978169228, language=CN, orderNo=2, keyword=审评审批), Keyword(id=1330184414790791592, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184410978169228, language=CN, orderNo=3, keyword=沟通机制), Keyword(id=1330184414883066281, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184410978169228, language=CN, orderNo=4, keyword=制度对比)], refs=[Reference(id=1330184415159890348, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184410978169228, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=LUNAWAT S, BHAT K. Complex generic products: insight of current regulatory frameworks in US, EU and Canada and the need of harmonisation [J]. Ther Innov Regul Sci, 2020,54(5): 991-1000., articleTitle=null, refAbstract=null), Reference(id=1330184415231193517, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184410978169228, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=DHULIA I, PATEL H, CHAUHAN N, et al. FDA’s drug regulatory pathways, its development strategies and regulatory considerations [J]. Int J Drug Regul Aff, 2021,9(2): 6-15., articleTitle=null, refAbstract=null), Reference(id=1330184415310885294, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184410978169228, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=PATEL H, DHULIA I, DOBARIYA U, et al. Regulatory aspects for competitive generic therapies in USA [J]. Int J Drug Regul Aff, 2021, 9(2): 16-19., articleTitle=null, refAbstract=null), Reference(id=1330184415369605551, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184410978169228, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=LUKE M C, KOZAK D. Regulating generic ophthalmologic drug bioequivalence—envisioning accessibility for patients[J]. J Ocul Pharmacol Ther, 2021, 37(3): 157-161., articleTitle=null, refAbstract=null), Reference(id=1330184415428325808, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184410978169228, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=SINGH R, SINGH S, KUMAR A, et al. Impact of generic drug user fee act and other initiatives on generic drug approval process in the USA [J]. J Pharm Res Health Care,2022, 14(1): 7., articleTitle=null, refAbstract=null), Reference(id=1330184415524794801, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184410978169228, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=LEE C Y, CHEN X H, ROMANELLI R J, et al. Forces influencing generic drug development in the United States:a narrative review [J]. J Pharm Policy and Pract, 2016,9(1): 26., articleTitle=null, refAbstract=null), Reference(id=1330184415705149874, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184410978169228, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=ALFORD P E. Rethinking FDA regulation of complex products [J]. Minn J L Sci & Tech, 2020, 21(2): 477., articleTitle=null, refAbstract=null), Reference(id=1330184415830978995, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184410978169228, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=ZHENG N, SUN D D, ZOU P, et al. Scientific and regulatory considerations for generic complex drug products containing nanomaterials [J]. AAPS J, 2017, 19(3): 619-631., articleTitle=null, refAbstract=null), Reference(id=1330184415898087860, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184410978169228, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA. Formal meetings between FDA and ANDA applicants of complex products under GDUFA guidance for industry[EB/OL]. (2020-11-24)[2022-12-25]. https://www.fda.gov/media/107626/download., articleTitle=null, refAbstract=null), Reference(id=1330184415961002421, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184410978169228, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA. Commitments For Complex Products. GDUFAⅡ[EB/OL]. (2016-12-5)[2022-12-25]. https://www.fda.gov/media/101052/download., articleTitle=null, refAbstract=null), Reference(id=1330184416036499894, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184410978169228, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA. Controlled Correspondence Related to Generic Drug Development Guidance for Industry [EB/OL]. (2020-12-16)[2022-12-25]. https://www.fda.gov/media/109232/download., articleTitle=null, refAbstract=null), Reference(id=1330184416124580279, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184410978169228, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=EMA-FDA Pilot Program. EMA-FDA Parallel Scientific Advice For Hybrid/Complex Generic Products-General Principles [EB/OL]. (2021-09-15) [2022-12-25]. https://www.fda.gov/media/152085/download., articleTitle=null, refAbstract=null), Reference(id=1330184416191689144, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184410978169228, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=国家食品药品监督管理局.《药物研发与技术审评沟通交流管理办法(试行)》(2016年第94号)[EB/OL].(2016-06-02)[2022-12-25].https://www.nmpa.gov.cn/xxgk/ggtg/qtggtg/20160606184101897.html., articleTitle=null, refAbstract=null), Reference(id=1330184416317518265, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184410978169228, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=国家药品监督管理局,药品审评中心.《药物研发与技术审评沟通交流管理办法》的通告(2020年第48号)[EB/OL].(2021-09-15)[2022-12-25].https://www.cde.org.cn/main/news/viewInfoCommon/b823ed10d547b1427a6906c6739fdf89., articleTitle=null, refAbstract=null)], funds=[Fund(id=1330184415000506794, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184410978169228, awardId=22YJAZH126, language=CN, fundingSource=教育部人文社会科学基金项目《医患视角下仿制药替代政策优化路径研究——基于政策“偏好-效果”模拟模型》(22YJAZH126), fundOrder=null, country=null), Fund(id=1330184415063421355, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184410978169228, awardId=72274217, language=CN, fundingSource=国家自然科学基金项目《我国基本药物目录覆盖疾病领域与疾病谱匹配度评价与提升研究——基于疾病优先性评价模型》(72274217), fundOrder=null, country=null)], companyList=[AuthorCompany(id=1330184411934470543, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184410978169228, xref=null, ext=[AuthorCompanyExt(id=1330184411947053456, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184410978169228, companyId=1330184411934470543, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Key Lab. of Drug Regulatory Innovation and Evaluation, NMPA, Research Institute of Drug Regulatory Sciences, China Pharmaceutical University, Nanjing 211198), AuthorCompanyExt(id=1330184411955442065, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184410978169228, companyId=1330184411934470543, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=中国药科大学药品监管科学研究院,国家药品监督管理局药品监管创新与评价重点实验室,江苏 南京 211198)])], figs=null, attaches=null, journal=Journal(id=1319689822849302687, delFlag=0, nameCn=中国医药工业杂志, nameEn=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, issn=1001-8255, eissn=null, cn=31-1243/R, coden=ZYGZEA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=etiWDuwx2KO274LHw88KJA==, journalPrice=null, startedYear=null, abbrevIsoEn=Chinese Journal of Pharmaceuticals, journalRemark=null, publicationField=null, createdTime=1792568172420, updatedTime=1792747450744, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=Z, firstLetterEn=Z, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=etiWDuwx2KO274LHw88KJA==, picEn=ip9NF4dK57AmNrCiZ6hmdw==, jcr=null, cjcr=null, exts=[JournalExt(id=1320441770761105589, language=CN, name=中国医药工业杂志, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450771, updatedTime=1792747450771, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""}), JournalExt(id=1320441770819825846, language=EN, name=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450785, updatedTime=1792747450785, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""})], databaseList=null, tenantJournalId=1319690259887390882, websiteList=[Website(id=1319720771623174732, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/CN, language=CN, createTime=1792575551181, createBy=18614031015, updateTime=1792746040843, updateBy=18614031015, name=中国医药工业杂志-中文, tplId=1146099689490845704, title=中国医药工业杂志, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428487504769041, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=articleTextType, value=kx, createTime=1792982702375, updateTime=1792982702375, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487475408910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982702368, updateTime=1792982702368, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487538323476, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=grayFlag, value=0, createTime=1792982702383, updateTime=1792982702383, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487462825997, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982702365, updateTime=1792982702365, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487571877910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=minRunFlag, value=0, createTime=1792982702391, updateTime=1792982702391, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487496380432, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic, createTime=1792982702373, updateTime=1792982702373, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487563489301, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=silenceFlag, value=0, createTime=1792982702389, updateTime=1792982702389, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487483797519, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982702370, updateTime=1792982702370, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487517351954, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeColor, value=null, createTime=1792982702378, updateTime=1792982702378, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487525740563, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982702380, updateTime=1792982702380, creator=18614031015, updator=18614031015)]), Website(id=1319720771702866512, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/EN, language=EN, createTime=1792575551200, createBy=18614031015, updateTime=1792746037543, updateBy=18614031015, name=中国医药工业杂志-英文, tplId=1146101810881728533, title=Chinese Journal of Pharmaceuticals, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428509638111261, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=articleTextType, value=kx, createTime=1792982707652, updateTime=1792982707652, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509579391002, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982707638, updateTime=1792982707638, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509680054304, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=grayFlag, value=0, createTime=1792982707662, updateTime=1792982707662, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509566808089, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982707635, updateTime=1792982707635, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509701025826, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=minRunFlag, value=0, createTime=1792982707667, updateTime=1792982707667, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509629722652, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic, createTime=1792982707650, updateTime=1792982707650, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509688442913, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=silenceFlag, value=0, createTime=1792982707664, updateTime=1792982707664, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509587779611, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982707640, updateTime=1792982707640, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509663277086, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeColor, value=null, createTime=1792982707658, updateTime=1792982707658, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509671665695, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982707660, updateTime=1792982707660, creator=18614031015, updator=18614031015)])], journalTitle=中国医药工业杂志, weixinUrl=null, journalUrl=http://www.cjph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=Chinese Journal of Pharmaceuticals, journalPhotoCn=etiWDuwx2KO274LHw88KJA==, journalPhotoEn=ip9NF4dK57AmNrCiZ6hmdw==, journalFirstLetter=Z, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2023.06.016, detailUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/10.16522/j.cnki.cjph.2023.06.016, pdfUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/PDF/10.16522/j.cnki.cjph.2023.06.016, pdfUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/PDF/10.16522/j.cnki.cjph.2023.06.016, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1686326400000, fullTextJson=null, articleText=null, reference=null)
收藏切换
FDA复杂仿制药审评审批沟通机制的简介与启示
史扬帆 , 龚小玲 , 颜建周 , 邵蓉 *
中国医药工业杂志 | 药学管理与信息 2023,54(6): 945-949
收起
收藏切换
中国医药工业杂志 |药学管理与信息 2023 , 54 (6) : 945 -949
FDA复杂仿制药审评审批沟通机制的简介与启示
全屏
[Author(id=1330184412026745235, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184410978169228, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330184412127408533, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184410978169228, authorId=1330184412026745235, language=EN, stringName=Yangfan SHI, firstName=Yangfan, middleName=null, lastName=SHI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Key Lab. of Drug Regulatory Innovation and Evaluation, NMPA, Research Institute of Drug Regulatory Sciences, China Pharmaceutical University, Nanjing 211198, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330184412202906006, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184410978169228, authorId=1330184412026745235, language=CN, stringName=史扬帆, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=中国药科大学药品监管科学研究院,国家药品监督管理局药品监管创新与评价重点实验室,江苏 南京 211198, bio={"content":"

史扬帆(1997—),男,硕士研究生,专业方向:医药政策与法规。

"}, bioImg=null, bioContent=

史扬帆(1997—),男,硕士研究生,专业方向:医药政策与法规。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330184411934470543, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184410978169228, xref=null, ext=[AuthorCompanyExt(id=1330184411947053456, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184410978169228, companyId=1330184411934470543, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Key Lab. of Drug Regulatory Innovation and Evaluation, NMPA, Research Institute of Drug Regulatory Sciences, China Pharmaceutical University, Nanjing 211198), AuthorCompanyExt(id=1330184411955442065, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184410978169228, companyId=1330184411934470543, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=中国药科大学药品监管科学研究院,国家药品监督管理局药品监管创新与评价重点实验室,江苏 南京 211198)])]), Author(id=1330184412265820568, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184410978169228, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330184412383261082, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184410978169228, authorId=1330184412265820568, language=EN, stringName=Xiaoling GONG, firstName=Xiaoling, middleName=null, lastName=GONG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Key Lab. of Drug Regulatory Innovation and Evaluation, NMPA, Research Institute of Drug Regulatory Sciences, China Pharmaceutical University, Nanjing 211198, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330184412467147163, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184410978169228, authorId=1330184412265820568, language=CN, stringName=龚小玲, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=中国药科大学药品监管科学研究院,国家药品监督管理局药品监管创新与评价重点实验室,江苏 南京 211198, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330184411934470543, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184410978169228, xref=null, ext=[AuthorCompanyExt(id=1330184411947053456, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184410978169228, companyId=1330184411934470543, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Key Lab. of Drug Regulatory Innovation and Evaluation, NMPA, Research Institute of Drug Regulatory Sciences, China Pharmaceutical University, Nanjing 211198), AuthorCompanyExt(id=1330184411955442065, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184410978169228, companyId=1330184411934470543, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=中国药科大学药品监管科学研究院,国家药品监督管理局药品监管创新与评价重点实验室,江苏 南京 211198)])]), Author(id=1330184412559421853, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184410978169228, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330184412626530719, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184410978169228, authorId=1330184412559421853, language=EN, stringName=Jianzhou YAN, firstName=Jianzhou, middleName=null, lastName=YAN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Key Lab. of Drug Regulatory Innovation and Evaluation, NMPA, Research Institute of Drug Regulatory Sciences, China Pharmaceutical University, Nanjing 211198, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330184412739776928, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184410978169228, authorId=1330184412559421853, language=CN, stringName=颜建周, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=中国药科大学药品监管科学研究院,国家药品监督管理局药品监管创新与评价重点实验室,江苏 南京 211198, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330184411934470543, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184410978169228, xref=null, ext=[AuthorCompanyExt(id=1330184411947053456, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184410978169228, companyId=1330184411934470543, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Key Lab. of Drug Regulatory Innovation and Evaluation, NMPA, Research Institute of Drug Regulatory Sciences, China Pharmaceutical University, Nanjing 211198), AuthorCompanyExt(id=1330184411955442065, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184410978169228, companyId=1330184411934470543, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=中国药科大学药品监管科学研究院,国家药品监督管理局药品监管创新与评价重点实验室,江苏 南京 211198)])]), Author(id=1330184412806885794, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184410978169228, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=shaorong118@163.com, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1330184412882383268, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184410978169228, authorId=1330184412806885794, language=EN, stringName=Rong SHAO, firstName=Rong, middleName=null, lastName=SHAO, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=Key Lab. of Drug Regulatory Innovation and Evaluation, NMPA, Research Institute of Drug Regulatory Sciences, China Pharmaceutical University, Nanjing 211198, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330184412957880741, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184410978169228, authorId=1330184412806885794, language=CN, stringName=邵蓉, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=中国药科大学药品监管科学研究院,国家药品监督管理局药品监管创新与评价重点实验室,江苏 南京 211198, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330184411934470543, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184410978169228, xref=null, ext=[AuthorCompanyExt(id=1330184411947053456, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184410978169228, companyId=1330184411934470543, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Key Lab. of Drug Regulatory Innovation and Evaluation, NMPA, Research Institute of Drug Regulatory Sciences, China Pharmaceutical University, Nanjing 211198), AuthorCompanyExt(id=1330184411955442065, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184410978169228, companyId=1330184411934470543, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=中国药科大学药品监管科学研究院,国家药品监督管理局药品监管创新与评价重点实验室,江苏 南京 211198)])])]
史扬帆, 龚小玲, 颜建周, 邵蓉*
作者信息
  • 中国药科大学药品监管科学研究院,国家药品监督管理局药品监管创新与评价重点实验室,江苏 南京 211198
通讯作者:
邵蓉(1962—),女,教授,博士生导师,从事医药政策与法规的研究。E-mail:
作者简介:

史扬帆(1997—),男,硕士研究生,专业方向:医药政策与法规。

Introduction and Enlightenment on Communication Mechanism of FDA Review and Approval of Complex Generic Drugs
Yangfan SHI, Xiaoling GONG, Jianzhou YAN, Rong SHAO*
Affiliations
  • Key Lab. of Drug Regulatory Innovation and Evaluation, NMPA, Research Institute of Drug Regulatory Sciences, China Pharmaceutical University, Nanjing 211198
出版时间: 2023-06-10 doi: 10.16522/j.cnki.cjph.2023.06.016
文章导航
收藏切换

该文通过查阅官方文件和研究文献,梳理、分析了FDA复杂仿制药注册审评过程中的沟通机制,从会议目标、细分类型、申请审核时限和会议程序几方面进行阐述,结合我国复杂仿制药审评审批沟通机制的现状,对两国复杂仿制药审评审批沟通机制进行对比和思考。FDA复杂仿制药沟通机制分为仿制药上市申请提交前程序、书面咨询和同步科学建议程序,通过细分的会议类型充分解决了复杂仿制药研发过程中审评审批层面的难题。建议我国可参考FDA做法,探索多样化的复杂仿制药沟通机制,从而提高审评效率,加快具有临床价值的复杂仿制药上市。

复杂仿制药  /  审评审批  /  沟通机制  /  制度对比
史扬帆, 龚小玲, 颜建周, 邵蓉. FDA复杂仿制药审评审批沟通机制的简介与启示. 中国医药工业杂志, 2023 , 54 (6) : 945 -949 . DOI: 10.16522/j.cnki.cjph.2023.06.016
Yangfan SHI, Xiaoling GONG, Jianzhou YAN, Rong SHAO. Introduction and Enlightenment on Communication Mechanism of FDA Review and Approval of Complex Generic Drugs[J]. Chinese Journal of Pharmaceuticals, 2023 , 54 (6) : 945 -949 . DOI: 10.16522/j.cnki.cjph.2023.06.016
  • 教育部人文社会科学基金项目《医患视角下仿制药替代政策优化路径研究——基于政策“偏好-效果”模拟模型》(22YJAZH126)
  • 国家自然科学基金项目《我国基本药物目录覆盖疾病领域与疾病谱匹配度评价与提升研究——基于疾病优先性评价模型》(72274217)
参考文献 引证文献
排序方式:
[1]
LUNAWAT S, BHAT K. Complex generic products: insight of current regulatory frameworks in US, EU and Canada and the need of harmonisation [J]. Ther Innov Regul Sci, 2020,54(5): 991-1000.
[2]
DHULIA I, PATEL H, CHAUHAN N, et al. FDA’s drug regulatory pathways, its development strategies and regulatory considerations [J]. Int J Drug Regul Aff, 2021,9(2): 6-15.
[3]
PATEL H, DHULIA I, DOBARIYA U, et al. Regulatory aspects for competitive generic therapies in USA [J]. Int J Drug Regul Aff, 2021, 9(2): 16-19.
[4]
LUKE M C, KOZAK D. Regulating generic ophthalmologic drug bioequivalence—envisioning accessibility for patients[J]. J Ocul Pharmacol Ther, 2021, 37(3): 157-161.
[5]
SINGH R, SINGH S, KUMAR A, et al. Impact of generic drug user fee act and other initiatives on generic drug approval process in the USA [J]. J Pharm Res Health Care,2022, 14(1): 7.
[6]
LEE C Y, CHEN X H, ROMANELLI R J, et al. Forces influencing generic drug development in the United States:a narrative review [J]. J Pharm Policy and Pract, 2016,9(1): 26.
[7]
ALFORD P E. Rethinking FDA regulation of complex products [J]. Minn J L Sci & Tech, 2020, 21(2): 477.
[8]
ZHENG N, SUN D D, ZOU P, et al. Scientific and regulatory considerations for generic complex drug products containing nanomaterials [J]. AAPS J, 2017, 19(3): 619-631.
[9]
FDA. Formal meetings between FDA and ANDA applicants of complex products under GDUFA guidance for industry[EB/OL]. (2020-11-24)[2022-12-25]. https://www.fda.gov/media/107626/download.
[10]
FDA. Commitments For Complex Products. GDUFAⅡ[EB/OL]. (2016-12-5)[2022-12-25]. https://www.fda.gov/media/101052/download.
[11]
FDA. Controlled Correspondence Related to Generic Drug Development Guidance for Industry [EB/OL]. (2020-12-16)[2022-12-25]. https://www.fda.gov/media/109232/download.
[12]
EMA-FDA Pilot Program. EMA-FDA Parallel Scientific Advice For Hybrid/Complex Generic Products-General Principles [EB/OL]. (2021-09-15) [2022-12-25]. https://www.fda.gov/media/152085/download.
[13]
国家食品药品监督管理局.《药物研发与技术审评沟通交流管理办法(试行)》(2016年第94号)[EB/OL].(2016-06-02)[2022-12-25].https://www.nmpa.gov.cn/xxgk/ggtg/qtggtg/20160606184101897.html.
[14]
国家药品监督管理局,药品审评中心.《药物研发与技术审评沟通交流管理办法》的通告(2020年第48号)[EB/OL].(2021-09-15)[2022-12-25].https://www.cde.org.cn/main/news/viewInfoCommon/b823ed10d547b1427a6906c6739fdf89.
2023年第54卷第6期
27
8
0
引用本文
BibTeX
文章信息
doi: 10.16522/j.cnki.cjph.2023.06.016
  • 接收时间:2023-01-10
  • 首发时间:2026-11-19
  • 出版时间:2023-06-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2023-01-10
基金
教育部人文社会科学基金项目《医患视角下仿制药替代政策优化路径研究——基于政策“偏好-效果”模拟模型》(22YJAZH126)
国家自然科学基金项目《我国基本药物目录覆盖疾病领域与疾病谱匹配度评价与提升研究——基于疾病优先性评价模型》(72274217)
作者信息
    中国药科大学药品监管科学研究院,国家药品监督管理局药品监管创新与评价重点实验室,江苏 南京 211198

通讯作者:

邵蓉(1962—),女,教授,博士生导师,从事医药政策与法规的研究。E-mail:
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2023.06.016
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏